Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heavy metal containing doai
Patent
1991-11-27
1994-02-15
Griffin, Ronald W.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heavy metal containing doai
424435, 424440, 424464, 424468, 514964, 514965, 514948, 514974, A61K 920, A61K 31315, A01N 5502
Patent
active
052867480
ABSTRACT:
Compositions and a general method are described to shorten the duration of common colds by administration of medicaments to and into the oral tissues, rather than to the nose, or by injection or by oral administration. Compositions for oral absorption by a human contain medicinal agents including antiviral agents, antirhinoviral agents, interferon, interferon inducers, T-cell lymphocyte mitogens and other agents desirable or theoretically useful in shortening the duration of common colds. All compositions include medicaments contained in a consumable, sweet pharmaceutical carrier, prepared in the form of a pleasant tasting lozenge, powder, liquid or chewable composition. All compositions are for delivery of medicinal agent to the oral and oral pharyngeal mucosa of a human with said composition being absent the normal offensive aftertaste of medicinal agent, and being intended for use in shortening the duration of common colds. The application specifically claims the discovery of utility of the application of medicinal agents to the oral and oralpharyngeal mucous membranes rather than the nose or by ingestion as the preferred method of administration of medicaments to shorten the duration of the common cold.
REFERENCES:
patent: Re33465 (1990-11-01), Eby
patent: 2540253 (1951-02-01), Gakenheimer
patent: 3331696 (1967-07-01), Rieckmann et al.
patent: 3598122 (1971-08-01), Zaffaroni
patent: 3789119 (1974-01-01), Fusari et al.
patent: 3911099 (1975-10-01), DeFoney et al.
patent: 3972995 (1976-08-01), Tsuk et al.
patent: 4024520 (1977-05-01), Palm
patent: 4059686 (1977-11-01), Tanaka et al.
patent: 4115544 (1978-09-01), Shell
patent: 4382924 (1983-05-01), Berling et al.
patent: 4474753 (1984-10-01), Haslam et al.
patent: 4503070 (1985-03-01), Eby
patent: 4551329 (1985-11-01), Harris et al.
patent: 4572832 (1986-02-01), Kigasawa et al.
patent: 4684534 (1987-08-01), Valentine
patent: 4747881 (1988-05-01), Shaw et al.
patent: 4764364 (1988-08-01), Heller et al.
patent: 4764378 (1988-08-01), Keith et al.
patent: 4843098 (1989-06-01), Shaw et al.
patent: 4915948 (1990-04-01), Gallopo et al.
patent: 5002970 (1991-03-01), Eby
patent: 5024997 (1991-06-01), Motola et al.
patent: 5059416 (1991-10-01), Cherukuri et al.
patent: 5073374 (1991-12-01), McCarty
"Reduction in Duration of Common Colds by Zinc Gluconate Lozenges in a Double-Blind Study", G. A. Eby et al., 1984, Antimicrob. Agents Chemother.
"Prophylaxis & Treatment of Rhinovirus Colds with Zinc Gluconate Lozenges", W. Al-Nakib et al., 1987, J. of Antimicrob. Chemother.
"Zinc Gluconate & The Common Cold: A Controlled Clinical Study", J. C. Godfrey et al., 1992, J. International Medical Research.
"Cotton Bract Tannin: A Novel Human T-Lymphocyte Mitogen and a Possible Causative Agent of Byssinosis", Vuk-Pavlovic, Int. Arch. Appl. Immunol., 1988.
"Induction of Interleukin-1-Beta Release from Human Monocytes by Cotton Bract Tannin", Vuk-Pavlovic et al., 1990, Int. Arch Allergy Immunol.
"Distribution and Removal of Human Serum Albumin-Technetium 99m Instilled Intranasally", 1976, Brit. J. Clin. Pharmac.
LandOfFree
General method of shortening the duration of common colds by app does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with General method of shortening the duration of common colds by app, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and General method of shortening the duration of common colds by app will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1207255